GGrantIndex
Sort

15,273 grants matching antimicrobial resistance

Neutrophil Function in Bacterial Pneumonia

$369,629
Samithamby Jeyaseelan · Louisiana State Univ A&M Col Baton Rouge · R01 · FY2017 · AI

Neutrophil Function in Bacterial Pneumonia

$369,629
Samithamby Jeyaseelan · Louisiana State Univ A&M Col Baton Rouge · R01 · FY2019 · AI

Neutrophil Function in Bacterial Pneumonia

$369,629
Samithamby Jeyaseelan · Louisiana State Univ A&M Col Baton Rouge · R01 · FY2016 · AI

Development of Infection-Resistant Suture Materials

$369,619
Matthew Douglas Phaneuf · Biosurfaces · R42 · FY2007 · HL

Strategies to Investigate Synergy in Botanical Medicines

$369,527
Nadja B Cech · University Of North Carolina Greensboro · R01 · FY2013 · AT

Neutrophil Accumulation in Bacterial Pneumonia

$369,472
Samithamby Jeyaseelan · Louisiana State Univ A&M Col Baton Rouge · R01 · FY2016 · HL

Analysis of interacellular host defenses in Salmonella pathogenesis

$369,464
Andres Vazquez-Torres · University Of Colorado Denver · R01 · FY2013 · AI

Neutrophil Accumulation in Bacterial Pneumonia

$369,456
Samithamby Jeyaseelan · Louisiana State Univ A&M Col Baton Rouge · R01 · FY2017 · HL

Function and inhibition of multidrug efflux systems in Campylobacter

$369,421
Qijing Zhang · Iowa State University · R01 · FY2020 · AI

Subproject 2 C. elegans-Mediated Discovery of Antimicrobial Compounds Against MRSA and VRE

$369,406
Frederick M Ausubel · Massachusetts Eye And Ear Infirmary · P01 · FY2019 · AI

Design of New Antimicrobials

$369,398
Robert S Hodges · University Of Colorado Denver · R01 · FY2009 · AI

Virulence determinants of Fusobacterium nucleatum

$369,380
Hung Ton-That · University Of California Los Angeles · R01 · FY2021 · DE

Ceftriaxone Immunomodulation and Antimicrobial Effects After Cardiac Arrest

$369,314
David Gagnon · Mainehealth · P20 · FY2024 · GM

Subproject 1 Compounds and Strategies for Treating MRSA and VRE

$369,257
Suzanne L. Walker · Massachusetts Eye And Ear Infirmary · P01 · FY2017 · AI

Pathway from Functional Disability to Antimicrobial Resistance in Nursing Homes

$369,252
Lona Mody · University Of Michigan At Ann Arbor · R01 · FY2017 · AG

Pathway from Functional Disability to Antimicrobial Resistance in Nursing Homes

$369,252
Lona Mody · University Of Michigan At Ann Arbor · R01 · FY2014 · AG

From Functional Disability to Antimicrobial Resistance in Nursing Home Residents

$369,252
Lona Mody · University Of Michigan At Ann Arbor · R01 · FY2013 · AG

Silver carbene complexes as treatment of CF lung disease

$369,121
Carolyn Louise Cannon · Washington University · R01 · FY2006 · AI

Quinolone Resistance Mechanisms in Staphylococcus aureus

$369,080
David C Hooper · Massachusetts General Hospital · R01 · FY2007 · AI

Control of Facial Amphiphilicity to Tune Macromolecular Interactions with Bacteria

$369,070
Chuanbing Tang · University Of South Carolina At Columbia · R01 · FY2020 · AI

Infectious Diseases and Microbial Immunology Post-doctoral Training Program

$369,060
Guy Hughes Palmer · Washington State University · T32 · FY2016 · AI

Impact of Staphylococcus aureus in osteomyelitis and bone physiology

$369,022
Mark S Smeltzer · Univ Of Arkansas For Med Scis · R01 · FY2015 · AI

Impact of Staphylococcus aureus in osteomyelitis and bone physiology

$369,022
Mark S Smeltzer · Univ Of Arkansas For Med Scis · R01 · FY2019 · AI

Impact of Staphylococcus aureus in osteomyelitis and bone physiology

$369,022
Mark S Smeltzer · Univ Of Arkansas For Med Scis · R01 · FY2016 · AI

Impact of Staphylococcus aureus in osteomyelitis and bone physiology

$369,022
Mark S Smeltzer · Univ Of Arkansas For Med Scis · R01 · FY2017 · AI